You may recall that a while
back I released an e-book about Alzheimer’s disease and the potential
therapeutic role of a low-carbohydrate, high-fat diet and other lifestyle
interventions. Well, I’m happy to announce that the book has been completely
rewritten and expanded for release this month as a print book from Chelsea Green Publishing, with a foreword by none other
than David Perlmutter, MD, author of the #1 New
York Times bestseller, Grain Brain!!
Chelsea Green is a big deal, folks. They publish the fermentation bible, a.k.a. Wild Fermentation, by Sandor Katz. They are also the U.S. distributor for Dr. Natasha Campbell McBride’s books—Put Your Heart in Your Mouth and Gut and Psychology Syndrome (the original GAPS™ diet book), which are both outstanding. They’re also the U.S. publishers for The Ketogenic Kitchen, by Domini Kemp and Patricia Daly. (Patricia is Ireland and the U.K.’s go-to gal for all things related to keto for cancer.) CG is also publishing the new release of Travis Christofferson’s Tripping Over the Truth (which I reviewed here) – the book that inspired my blog series on the metabolic theory of cancer. So you can see I am in very, very good company among these folks.
Chelsea Green is a big deal, folks. They publish the fermentation bible, a.k.a. Wild Fermentation, by Sandor Katz. They are also the U.S. distributor for Dr. Natasha Campbell McBride’s books—Put Your Heart in Your Mouth and Gut and Psychology Syndrome (the original GAPS™ diet book), which are both outstanding. They’re also the U.S. publishers for The Ketogenic Kitchen, by Domini Kemp and Patricia Daly. (Patricia is Ireland and the U.K.’s go-to gal for all things related to keto for cancer.) CG is also publishing the new release of Travis Christofferson’s Tripping Over the Truth (which I reviewed here) – the book that inspired my blog series on the metabolic theory of cancer. So you can see I am in very, very good company among these folks.
My book, The Alzheimer’s Antidote: Using a Low-Carb, High-Fat Diet to Fight Alzheimer’s Disease, Memory Loss, and Cognitive Decline, has been rewritten and expanded with new and even more powerful information, all of
which only strengthens my basic premise: Alzheimer’s disease is, at least in
part, a systemic metabolic condition, and as such, there are dietary and
lifestyle interventions that could potentially stop or slow the progression of
this condition, and possibly even reverse some of the damage that has already
occurred.
One of the fundamental aspects of Alzheimer’s disease
is that neurons in regions of the brain involved in memory processing lose the
ability to metabolize glucose efficiently. In fact, in noting that Alzheimer’s
patients show as much as a 45% reduction in cerebral glucose utilization, one
study’s authors said that this is “the predominant abnormality in incipient late onset Alzheimer’s disease...” This is not a matter of debate. There are many things we don’t know and don’t understand about Alzheimer’s disease. This isn’t one of them. That metabolic issues involving perturbed glucose and insulin processing in the
brain are major factors either directly causing or at least exacerbating
Alzheimer’s pathology and progression are so undeniable that the phrases “type 3 diabetes,” “brain insulin resistance,” and “metabolic-cognitive syndrome” are now regularly used in the scientific literature. (Yep, you already
knew about plain ol’ metabolic syndrome, but when you throw dementia and cognitive
impairment into the mix, you have metabolic-cognitive
syndrome.) The reduction in cerebral glucose metabolism is not controversial. The controversy lies in what causes this and what to do about it.


